These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26950376)

  • 61. Reduced intensity allogeneic hematopoietic stem cell transplantation is a safe and effective treatment option in high-risk myeloma patients - a single centre experience.
    Jurgensen-Rauch A; Gibbs S; Farrell M; Aries J; Grantham M; Eccersley L; Gribben J; Hallam S; Oakervee H; Cavenagh J; Davies J; Sive J
    Br J Haematol; 2021 Apr; 193(2):420-423. PubMed ID: 33713421
    [No Abstract]   [Full Text] [Related]  

  • 62. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
    Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
    Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Outcomes Among High-Risk and Standard-Risk Multiple Myeloma Patients Treated With High-Dose Chemotherapy and Autologous Hematopoietic Stem-Cell Transplantation.
    Kazmi SM; Nusrat M; Gunaydin H; Cornelison AM; Shah N; Kebriaei P; Nieto Y; Parmar S; Popat UR; Oran B; Shah JJ; Orlowski RZ; Champlin RE; Qazilbash MH; Bashir Q
    Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):687-93. PubMed ID: 26361647
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mobilization of Hematopoietic Stem Cells for Hematopoietic Cells Autologous Transplantation with Use of Plerixafor.
    Gawroński K; Rzepecki P; Sawicki W; Wajs J
    Ann Transplant; 2017 May; 22():296-302. PubMed ID: 28496091
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Autologous transplantation with peripheral blood stem cells: a review of clinical results.
    Kessinger A
    J Clin Apher; 1990; 5(2):97-9. PubMed ID: 1967604
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Autologous stem cell transplantation in first remission is associated with better progression-free survival in multiple myeloma.
    Aggarwal M; Agrawal N; Yadav N; Verma P; Ahmed R; Mehta P; Kapoor J; Bhurani D
    Ann Hematol; 2018 Oct; 97(10):1869-1877. PubMed ID: 29781040
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma.
    Poenisch W; Plötze M; Holzvogt B; Andrea M; Schliwa T; Zehrfeld T; Hammerschmidt D; Schwarz M; Edelmann T; Becker C; Hoffmann FA; Schwarzer A; Kreibich U; Gutsche K; Reifenrath K; Schwarzbach H; Heyn S; Franke GN; Jentzsch M; Leiblein S; Schwind S; Lange T; Vucinic V; AlAli HK; Niederwieser D
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):2013-22. PubMed ID: 25976868
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recovery of polyclonal immunoglobulins one year after autologous stem cell transplantation as a long-term predictor marker of progression and survival in multiple myeloma.
    González-Calle V; Cerdá S; Labrador J; Sobejano E; González-Mena B; Aguilera C; Ocio EM; Vidriales MB; Puig N; Gutiérrez NC; García-Sanz R; Alonso JM; López R; Aguilar C; de Coca AG; Hernández R; Hernández JM; Escalante F; Mateos MV
    Haematologica; 2017 May; 102(5):922-931. PubMed ID: 28126960
    [TBL] [Abstract][Full Text] [Related]  

  • 69. High incidence of symptomatic cytomegalovirus infection in multiple myeloma patients undergoing autologous peripheral blood stm cell transplantation.
    Alessandrino EP; Varettoni M; Colombo AA; Caldera D; Bernasconi P; Malcovati L
    Blood; 2000 Jun; 95(12):4016-8. PubMed ID: 10939798
    [No Abstract]   [Full Text] [Related]  

  • 70. [Multiple myeloma; treatment in the year 1998].
    Lokhorst HM; Sonneveld P; Wijermans PW; Segeren CM
    Ned Tijdschr Geneeskd; 1998 Jul; 142(28):1596-602. PubMed ID: 9763840
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma.
    Huang SY; Lin HH; Lin CW; Li CC; Yao M; Tang JL; Hou HA; Tsay W; Chou SJ; Cheng CL; Tien HF
    Oncotarget; 2016 Sep; 7(38):62490-62502. PubMed ID: 27566569
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Biosimilars of filgrastim in autologous stem cell transplant: reduction in granulocyte-colony stimulating factor costs, but similar effects on bone marrow recovery.
    Ianotto JC; Ngo Sack F; Couturier MA; Tempescul A; Mugnier N; Delepine P; Guillerm G; Berthou C
    Leuk Lymphoma; 2014 Jan; 55(1):74-7. PubMed ID: 23566160
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hepatitis reactivation and liver failure in haemopoietic stem cell transplants for hepatitis B virus (HBV)/hepatitis C virus (HCV) positive recipients: a retrospective study by the Italian group for blood and marrow transplantation.
    Locasciulli A; Bruno B; Alessandrino EP; Meloni G; Arcese W; Bandini G; Cassibba V; Rotoli B; Morra E; Majolino I; Alberti A; Bacigalupo A;
    Bone Marrow Transplant; 2003 Feb; 31(4):295-300. PubMed ID: 12621466
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety and survival outcomes for bloodless transplantation in patients with myeloma.
    Joseph NS; Kaufman JL; Boise LH; Valla K; Almaula DK; Obidike CO; Langston AA; Waller EK; Khoury HJ; Flowers CR; Graiser M; Heffner LT; Lonial S; Nooka AK
    Cancer; 2019 Jan; 125(2):185-193. PubMed ID: 30480777
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison between autologous and allogeneic stem cell transplantation as salvage therapy for multiple myeloma relapsing/progressing after autologous stem cell transplantation.
    Ikeda T; Mori K; Kawamura K; Mori T; Hagiwara S; Ueda Y; Kahata K; Uchida N; Tsukada N; Murakami S; Yamamoto M; Takahashi T; Ichinohe T; Onizuka M; Atsuta Y; Kanda Y; Okamoto S; Sunami K; Takamatsu H
    Hematol Oncol; 2019 Dec; 37(5):586-594. PubMed ID: 31674032
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Conditioning-based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991-2012) on behalf of EBMT CMWP.
    Hayden PJ; Iacobelli S; Pérez-Simón JA; van Biezen A; Minnema M; Niittyvuopio R; Schönland S; Meijer E; Blaise D; Milpied N; Márquez-Malaver FJ; Veelken JH; Maertens J; Michallet M; Cammenga J; N'Guyen S; Niederwieser D; Hunault-Berger M; Bourhis JH; Passweg J; Bermudez A; Chalandon Y; Yakoub-Agha I; Garderet L; Kröger N
    Eur J Haematol; 2020 Mar; 104(3):181-189. PubMed ID: 31737951
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation.
    Lin CJ; Vader JM; Slade M; DiPersio JF; Westervelt P; Romee R
    Cancer; 2017 May; 123(10):1800-1809. PubMed ID: 28262921
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The addition of plerixafor is safe and allows adequate PBSC collection in multiple myeloma and lymphoma patients poor mobilizers after chemotherapy and G-CSF.
    D'Addio A; Curti A; Worel N; Douglas K; Motta MR; Rizzi S; Dan E; Taioli S; Giudice V; Agis H; Kopetzky G; Soutar R; Casadei B; Baccarani M; Lemoli RM
    Bone Marrow Transplant; 2011 Mar; 46(3):356-63. PubMed ID: 20577218
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma.
    Adkins DR; Salzman D; Boldt D; Kuhn J; Irvin R; Roodman GD; Lyons R; Smith L; Freytes CO; LeMaistre CF
    J Clin Oncol; 1994 Sep; 12(9):1890-901. PubMed ID: 7916039
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma.
    Maffini E; Storer BE; Sandmaier BM; Bruno B; Sahebi F; Shizuru JA; Chauncey TR; Hari P; Lange T; Pulsipher MA; McSweeney PA; Holmberg L; Becker PS; Green DJ; Mielcarek M; Maloney DG; Storb R
    Haematologica; 2019 Feb; 104(2):380-391. PubMed ID: 30262560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.